Rep. Sewell praises FDA approval of breakthrough pancreatic cancer drug
5 Articles
5 Articles
Effective treatments for pancreatic cancer have been slow to emerge. Now, a promising new drug has been approved in the United States.
A revolutionary medicine for pancreatic cancer, which doubles the patient survival rate, has been approved in the U.S. Food and Drug Agency (FDA) approved the medicine developed by Revolution Medicines for the treatment of advanced pancreatic cancer, after clinical studies have shown that it doubles the survival rate of patients at advanced stages of the disease. The approval gives new hope to people diagnosed with one of the most aggressive and…
Drug was approved in the United States, with Europe preparing to do the same. It costs about 34,000 euros for each month of treatment and doubled the survival rate of patients.
The US Food and Drug Administration (FDA) has approved a treatment for pancreatic cancer that in clinical trials almost doubled the total time pr
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
